MedTrace Logo

The Development of Diagnosis and Prognosis Predictive Model for Peripheral Nerve Disease

NCT06843642 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2025-02-25

No results posted yet for this study

Summary

This is a retrospective observational cohort study (MRN-PND), aiming to explore the utility of contrast-enhanced MRN (ceMRN) compared to plain MRN in diagnosing peripheral nerve diseases and predicting the prognosis of patients with these conditions. Additionally, artificial intelligence (AI) methods are employed to enhance the diagnostic accuracy of MRN for peripheral nerve diseases and to precisely predict disease outcomes.

Conditions

  • Peripheral Nerve Disease

Sponsors & Collaborators

  • Wuhan No.1 Hospital

    collaborator OTHER

  • University Hospital Heidelberg

    collaborator OTHER

  • West China Hospital

    collaborator OTHER

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2025-01-01
Completion
2025-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06843642 on ClinicalTrials.gov